Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation.

IF 2.6 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Arrhythmia & Electrophysiology Review Pub Date : 2023-01-01 DOI:10.15420/aer.2022.31
David M Harmon, Ojasav Sehrawat, Maren Maanja, John Wight, Peter A Noseworthy
{"title":"Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation.","authors":"David M Harmon,&nbsp;Ojasav Sehrawat,&nbsp;Maren Maanja,&nbsp;John Wight,&nbsp;Peter A Noseworthy","doi":"10.15420/aer.2022.31","DOIUrl":null,"url":null,"abstract":"<p><p>AF is the most common clinically relevant cardiac arrhythmia associated with multiple comorbidities, cardiovascular complications (e.g. stroke) and increased mortality. As artificial intelligence (AI) continues to transform the practice of medicine, this review article highlights specific applications of AI for the screening, diagnosis and treatment of AF. Routinely used digital devices and diagnostic technology have been significantly enhanced by these AI algorithms, increasing the potential for large-scale population-based screening and improved diagnostic assessments. These technologies have similarly impacted the treatment pathway of AF, identifying patients who may benefit from specific therapeutic interventions. While the application of AI to the diagnostic and therapeutic pathway of AF has been tremendously successful, the pitfalls and limitations of these algorithms must be thoroughly considered. Overall, the multifaceted applications of AI for AF are a hallmark of this emerging era of medicine.</p>","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"12 ","pages":"e12"},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b6/c0/aer-12-e12.PMC10326669.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arrhythmia & Electrophysiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/aer.2022.31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 2

Abstract

AF is the most common clinically relevant cardiac arrhythmia associated with multiple comorbidities, cardiovascular complications (e.g. stroke) and increased mortality. As artificial intelligence (AI) continues to transform the practice of medicine, this review article highlights specific applications of AI for the screening, diagnosis and treatment of AF. Routinely used digital devices and diagnostic technology have been significantly enhanced by these AI algorithms, increasing the potential for large-scale population-based screening and improved diagnostic assessments. These technologies have similarly impacted the treatment pathway of AF, identifying patients who may benefit from specific therapeutic interventions. While the application of AI to the diagnostic and therapeutic pathway of AF has been tremendously successful, the pitfalls and limitations of these algorithms must be thoroughly considered. Overall, the multifaceted applications of AI for AF are a hallmark of this emerging era of medicine.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能用于房颤的检测和治疗。
房颤是临床上最常见的心律失常,与多种合并症、心血管并发症(如卒中)和死亡率增加有关。随着人工智能(AI)不断改变医学实践,这篇综述文章重点介绍了人工智能在房颤筛查、诊断和治疗方面的具体应用。这些人工智能算法显著增强了常规使用的数字设备和诊断技术,增加了大规模人群筛查和改进诊断评估的潜力。这些技术同样影响了房颤的治疗途径,确定了可能从特定治疗干预中受益的患者。虽然人工智能在房颤诊断和治疗途径中的应用已经取得了巨大的成功,但必须彻底考虑这些算法的缺陷和局限性。总的来说,人工智能在房颤中的多方面应用是这个新兴医学时代的一个标志。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Arrhythmia & Electrophysiology Review
Arrhythmia & Electrophysiology Review CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
5.10
自引率
6.70%
发文量
22
审稿时长
7 weeks
期刊最新文献
Association Between Atrial Fibrillation and Long-term Mortality in Acute MI Patients. Incidence, Risk Factors and Predictors of Phantom Shocks in Patients with Implantable Cardioverter Defibrillators: State-of-the-art Review. Dynamic Voltage Mapping of the Post-infarct Ventricular Tachycardia Substrate: A Practical Technique to Help Differentiate Scar from Borderzone Tissue. Left Bundle Branch Block-associated Cardiomyopathy: A New Approach. Stylet-driven Leads or Lumenless Leads for Conduction System Pacing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1